Genmab — April 2021
-
GEN1046 Anticipated Enrollment ; large increase from 192 to 512
https://clinicaltrials.gov/ct2/history/NCT03917381?A=12&B=13&C=merged#StudyPageTop -
this Amivantamab trial adds a chemo cohort https://clinicaltrials.gov/ct2/history/NCT04077463?A=17&B=18&C=merged#StudyPageTop
-
Wow! Rather a large phase 1/2 study!!!
-
That corresponds well with the optimal dose-statements made by biontech, you found a couple of days ago
-
small new Dara
trial for prospective kidney transplant recipients Daratumumab and Belatacept for Desensitization (ATTAIN) https://clinicaltrials.gov/ct2/show/NCT04827979 -
En godkendelse til isa https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-isatuximab-irfc-multiple-myeloma?utm_medium=email&utm_source=govdelivery Ved ikke om det er en gammel nyhed på PI
-
Considering the attractiv evaluation, upcoming news flow on key pipeline programs epcoritamab, tisotumab,and GEN1046, and seeing Genmab as one of those typical stocks to own when markets are jittery, we add Genmab to our best value list. https://www.proinvestor.com/index.php?p=debat_1&postid=92506
-
-
God morgen.
-
God morgen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind